Open·Ingested 46 days ago, not re-verified since

DoW Duchenne Muscular Dystrophy, Idea Development Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)

Posted: Jun 17, 2026
Amount: $2,500,000
Closes: Sep 18, 2026 (in 47 days)

Similar opportunities open now

DoW Duchenne Muscular Dystrophy, Clinical/Translational Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 47 days
DoW Tick-Borne Disease Idea Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 81 days
DoW Bone Marrow Failure, Idea Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses Nov 2026
DoW Rare Cancers Idea Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses Nov 2026
DoW Kidney Cancer, Idea Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 57 days

Classification and identifiers

Solicitation number: HT942526DMDRPIDA
Assistance listing (CFDA): 12.420

Amount

$2,500,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory indiv...